These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1477008)

  • 1. Outcome of pregnancy following treatment of well-differentiated thyroid cancer with 131iodine.
    Balan KK; Critchley M
    Br J Obstet Gynaecol; 1992 Dec; 99(12):1021-2. PubMed ID: 1477008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Age of menopause in patients with differentiated thyroid cancer treated with radioiodine].
    Manuel García-Quirós Muñoz J; Martín Hernández T; Torres Cuadro A; Cambil Molina T; Castro Montaño J; Sendón Pérez A
    Endocrinol Nutr; 2010 Mar; 57(3):105-9. PubMed ID: 20304710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid suppression and radioiodine treatment for differentiated thyroid cancer.
    Rösler H
    Arch Otolaryngol Head Neck Surg; 1987 Jul; 113(7):778-9. PubMed ID: 3580165
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma.
    Yan W; Roach PJ; Bautovich GJ; Learoyd DL; Robinson BG
    Clin Nucl Med; 2007 May; 32(5):375-7. PubMed ID: 17452866
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroxine dosing after I131Radioiodine ablation for differentiated thyroid cancer.
    Clarke K; Gill V; Gerrard G
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):559-60. PubMed ID: 21530195
    [No Abstract]   [Full Text] [Related]  

  • 6. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
    Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
    Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blockade of iodine in thyroid cancer in known cases. Principles, effectiveness and actual cases].
    Reiners C
    Nuklearmedizin; 2006; 45(3):97-100. PubMed ID: 16710503
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer.
    Sioka C; Fotopoulos A
    Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome after 131I therapy.
    Sioka C; Fotopoulos A
    J Nucl Med; 2009 Feb; 50(2):327; author reply 327-8. PubMed ID: 19164224
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of multikinase inhibitor initiation in differentiated thyroid cancer.
    Brose MS; Smit J; Lin CC; Pitoia F; Fellous M; DeSanctis Y; Schlumberger M; Tori M; Sugitani I
    Endocr Relat Cancer; 2017 May; 24(5):237-242. PubMed ID: 28270435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of 131iodine therapy of benign thyroid diseases (author's transl)].
    Pronath A; Buttermann G; Dirr W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1970-4. PubMed ID: 6798434
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction. Thyroid cancer.
    CA Cancer J Clin; 1984; 34(5):299-302. PubMed ID: 6432242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
    Börner W; Reiners C
    Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
    [No Abstract]   [Full Text] [Related]  

  • 14. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
    Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge.
    Marotta V; Colao A; Faggiano A
    Endocrine; 2015 Dec; 50(3):824-5. PubMed ID: 25754914
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial.
    Schneider TC; Abdulrahman RM; Corssmit EP; Morreau H; Smit JW; Kapiteijn E
    Eur J Endocrinol; 2012 Nov; 167(5):643-50. PubMed ID: 22918300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new age for recombinant human thyroid-stimulating hormone?
    Medvedec M
    J Nucl Med; 2009 May; 50(5):832; author reply 832-3. PubMed ID: 19372486
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pregnancy in women with thyroid cancer treated with suppressive doses of L-thyroxine].
    Jastrzebska H; Gietka-Czernel M; Zgliczyński S; Czech W; Lewartowska A; Debski R
    Wiad Lek; 2001; 54 Suppl 1():389-97. PubMed ID: 12182055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary iodine in patients with differentiated thyroid cancer (DTC) during L-thyroxine treatment.
    Michalik B; Roskosz J; Stanjek-Cichoracka A; Krajewska J; Kalemba M; Kochańska-Dziurowicz A; Jarząb B
    Endokrynol Pol; 2010; 61(5):458-61. PubMed ID: 21049458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.